Recurrent membranous nephropathy in an allograft caused by IgG3k targeting the PLA2 receptor

Journal of the American Society of Nephrology

Volumn 23, Issue 12, 2012, Pages 1949-1954

  Debiec, Hanna ^a,b,c   Hanoy, Melanie ^d   Francois, Arnaud ^d,e   Guerrot, Dominique ^d   Ferlicot, Sophie ^f   Johanet, Catherine ^f   Aucouturier, Pierre ^g   Godin, Michel ^d,e   Ronco, Pierre ^a,b,c  

^a Urgences Néphrologiques et Transplantation Rénale Hôpital Tenon 4   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL TENON   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATININE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; JIR PROTEIN; PHOSPHOLIPASE A2 RECEPTOR; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CASE REPORT; CONFOCAL MICROSCOPY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; GLOMERULUS BASEMENT MEMBRANE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE;

EID: 84870511005     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2012060577     Document Type: Article

References (31)

1. Glassock RJ: The pathogenesis of idiopathic membranous nephropathy: A 50-year odyssey. Am J Kidney Dis 56: 157-167, 2010
2. Ohtani H, Wakui H, Komatsuda A, Okuyama S, Masai R, Maki N, Kigawa A, Sawada K, Imai H: Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 19: 574-579, 2004 (Pubitemid 38263115)
3. Segawa Y, Hisano S, Matsushita M, Fujita T, Hirose S, Takeshita M, Iwasaki H: IgG subclasses and complement pathway in segmental and global membranous nephropathy. Pediatr Nephrol 25: 1091-1099, 2010
4. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, Deschênes G, Ronco PM: Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346: 2053-2060, 2002 (Pubitemid 34680597)
5. Ronco P, Debiec H: Molecular pathomechanisms of membranous nephropathy: From Heymann nephritis to alloimmunization. J Am Soc Nephrol 16: 1205-1213, 2005 (Pubitemid 41716505)
6. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361: 11-21, 2009
7. 2- receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 26: 2526-2532, 2011
8. Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Liu Z: Anti-phospholipase A2 receptor antibody in membranous nephropathy. JAmSocNephrol 22: 1137-1143, 2011
9. Ronco P, Debiec H: Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat Rev Nephrol 8: 203-213, 2012
10. 2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6: 1286-1291, 2011
11. Beck LH Jr, Fervenza FC, Beck DM, Bonegio RG,Malik FA, Erickson SB, Cosio FG, Cattran DC, Salant DJ: Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 22: 1543-1550, 2011
12. Heymann W, Hackel DB, Harwood S, Wilson SGF, Hunter JL: Production of nephrotic syndrome in rats by Freund's adjuvants and rat kidney suspensions. Proc Soc Exp Biol Med 100: 660-664, 1959
13. Ronco P, Debiec H: Advances in membranous nephropathy: Success stories of a long journey. Clin Exp Pharmacol Physiol 38: 460-6, 2011
14. Debiec H, Ronco P: PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl JMed 364: 689-690, 2011
15. Stahl R, Hoxha E, Fechner K: PLA2R auto-antibodies and recurrent membranous nephropathy after transplantation. N Engl J Med 363: 496-498, 2010
16. Debiec H, Martin L, Jouanneau C, Dautin G, Mesnard L, Rondeau E, Mousson C, Ronco P: Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant 11: 2144-2152, 2011
17. Blosser CD, Ayalon R, Nair R, Thomas C, Beck LH Jr: Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation. Am J Transplant 12: 1637-1642, 2012
18. Bayle P, Laplanche G, Gorguet B, Oksman F, Boulinguez S, Bazex J: Neutrophilic dermatosis: A case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology 189: 69-71, 1994 (Pubitemid 24126377)
19. Cohavy O, Harth G, Horwitz M, Eggena M, Landers C, Sutton C, Targan SR, Braun J: Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's disease. Infect Immun 67: 6510-6517, 1999
20. Fervenza FC, Terreros D, Boutaud A, Hudson BG, Williams RA Jr, Donadio JV Jr, Schwab TR: Recurrent Goodpasture's disease due to a monoclonal IgA-kappa circulating antibody. Am J Kidney Dis 34: 549-555, 1999 (Pubitemid 29413629)
21. Borza DB, Chedid MF, Colon S, Lager DJ, Leung N, Fervenza FC: Recurrent Good-pasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45: 397-406, 2005 (Pubitemid 40431067)
22. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20: 2055-2064, 2009
23. Nasr SH, Sethi S, Cornell LD, Fidler ME, Boelkins M, Fervenza FC, Cosio FG, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits recurs in the allograft. Clin J Am Soc Nephrol 6: 122-132, 2011
24. Guiard E, Karras A, Plaisier E, Duong Van Huyen JP, Fakhouri F, Rougier JP, Noel LH, Callard P, Delahousse M, Ronco P: Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol 6: 1609-1616, 2011
25. Capra JD, Kunkel HG: Aggregation of gamma-G3 proteins: Relevance to the hyperviscosity syndrome. J Clin Invest 49: 610-621, 1970
26. Abdelmoula M, Spertini F, Shibata T, Gyotoku Y, Luzuy S, Lambert PH, Izui S: IgG3 is themajor source of cryoglobulins inmice. J Immunol 143: 526-532, 1989 (Pubitemid 19191547)
27. Ma H, Beck LH, Salant DJ: Membranous nephropathy-associated anti-phospholipase A2 receptor IgG4 autoantibodies activate the lectin complement pathway. [abstract] J Am Soc Nephrol 22: 62A, 2011
28. Lhotta K, Würzner R, König P: Glomerular deposition of mannose-binding lectin in human glomerulonephritis. Nephrol Dial Transplant 14: 881-886, 1999 (Pubitemid 29155140)
29. Van Damme BJ, Fleuren GJ, Bakker WW, Vernier RL, Hoedemaeker PJ: Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis. Lab Invest 38: 502-510, 1978 (Pubitemid 8338244)
30. Couser WG, Steinmuller DR, Stilmant MM, Salant DJ, Lowenstein LM: Experimental glomerulonephritis in the isolated perfused rat kidney. J Clin Invest 62: 1275-1287, 1978 (Pubitemid 9075757)
31. Ponticelli C, Altieri P, Scolari F, Passerini P, Roccatello D, Cesana B, Melis P, Valzorio B, Sasdelli M, Pasquali S, Pozzi C, Piccoli G, Lupo A, Segagni S, Antonucci F, Dugo M, MinariM, Scalia A, Pedrini L, PisanoG, Grassi C, Farina M, Bellazzi R: A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 9: 444-450, 1998 (Pubitemid 28122870)